Literature DB >> 8772719

Lymphocyte function associated antigen-1, integrin alpha 4, and L-selectin mediate T-cell homing to the pancreas in the model of adoptive transfer of diabetes in NOD mice.

N Fabien1, I Bergerot, J Orgiazzi, C Thivolet.   

Abstract

The involvement of adhesion molecule in the process of T-cell homing to the pancreas was investigated in the model of the T-cell transfer of type I diabetes in NOD mice. Treatment of mice using monoclonal anti-lymphocyte function associated antigen (LFA)-1, anti-integrin alpha 4, anti-intercellular adhesion molecule (ICAM)-1, and anti-L-selectin antibodies (monoclonal antibodies [mAbs]) gave rise to a partial or complete prevention of diabetes via different mechanisms of protection. On day 20 posttransfer, diabetes was only observed in control mice (26 of 32) and in few mice treated with the anti-L-selectin mAbs (3 of 24). On day 60, the best protection was observed using the anti-LFA-1 or the anti-integrin alpha 4 mAbs with 3 of 11 and 2 of 5 diabetic mice, respectively. On day 20, no insulitis was observed in the pancreases of mice treated with these mAbs compared with the pancreases of controls, suggesting that such treatment blocked the penetration of T-cells into the islets. In vitro adhesion assays confirmed that adhesion of T-cells to the pancreatic endothelium was blocked, except when using the anti-L-selectin mAb, which induced a modification of the traffic of the transferred T-cells; the ability of T-cells to migrate into the pancreatic lymph nodes was significantly reduced (10.4 vs. 22%). Anti-LFA-1 mAbs did not modify such T-cell trafficking. The present study, therefore, elucidates the role of LFA-1, integrin alpha 4, and L-selectin in T-cell homing to the pancreas, first step of the cascade of events leading to type I diabetes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772719     DOI: 10.2337/diab.45.9.1181

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  5 in total

1.  Jejuna of patients with insulin-dependent diabetes mellitus (IDDM) show signs of immune activation.

Authors:  E Savilahti; T Ormälä; T Saukkonen; U Sandini-Pohjavuori; J M Kantele; A Arato; J Ilonen; H K Akerblom
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Detection of a sulfotransferase (HEC-GlcNAc6ST) in high endothelial venules of lymph nodes and in high endothelial venule-like vessels within ectopic lymphoid aggregates: relationship to the MECA-79 epitope.

Authors:  Annette Bistrup; Durwin Tsay; Priti Shenoy; Mark S Singer; Naveen Bangia; Sanjiv A Luther; Jason G Cyster; Nancy H Ruddle; Steven D Rosen
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

3.  Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis.

Authors:  Jesús Rivera-Nieves; Tracy L Burcin; Timothy S Olson; Margaret A Morris; Marcia McDuffie; Fabio Cominelli; Klaus Ley
Journal:  J Exp Med       Date:  2006-03-27       Impact factor: 14.307

4.  Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells.

Authors:  Alexei Y Savinov; F Susan Wong; Austin C Stonebraker; Alexander V Chervonsky
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

5.  Genetic deficiency of Itgb2 or ItgaL prevents autoimmune diabetes through distinctly different mechanisms in NOD/LtJ mice.

Authors:  John D Glawe; D Ross Patrick; Meng Huang; Christopher D Sharp; Shayne C Barlow; Christopher G Kevil
Journal:  Diabetes       Date:  2009-02-17       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.